Reports for POTASSIUM CHLORIDE
Ingredient
POTASSIUM CHLORIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP | 149MG | SOLUTION | Resolved | 2019-03-20 | 2019-10-30 | 78955 |
LACTATED RINGER'S INJECTION, USP | 310MG 20MG 30MG 600MG | SOLUTION | Resolved | 2019-03-15 | 2019-03-30 | 78800 |
POTASSIUM CHLORIDE INJECTION | 14.9MG | LIQUID | Resolved | 2019-03-01 | 2019-03-07 | 77248 |
PLASMA-LYTE A INJECTION | 368MG 30MG 37MG 526MG 502MG | SOLUTION | Resolved | 2019-02-15 | 2019-03-19 | 76031 |
NXSTAGE PUREFLOW SOLUTION RFP-209-CAN | 8.408G 1.1G 0.102G 0.221G 0.15G 5.552G | SOLUTION | Resolved | 2019-02-15 | 2019-03-12 | 76025 |
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | 5G 150MG 450MG | SOLUTION | Resolved | 2019-02-08 | 2019-02-13 | 75200 |
POTASSIUM CHLORIDE INJECTION | 14.9MG | LIQUID | Resolved | 2019-01-25 | 2019-02-05 | 73584 |
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP | 149MG | SOLUTION | Resolved | 2019-01-08 | 2019-08-21 | 71580 |
POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-12-14 | 2018-12-20 | 69676 |
NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305) | 176.5G 23.1G 2.13G 4.63G 1.57G 116.6G | SOLUTION | Resolved | 2018-12-03 | 2019-06-11 | 68419 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACID CONCENTRATE 2139 | 89.99G 8.11G 3.21G 7.74G 10.06G 268.24G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7243 |
ACID CONCENTRATE 2125 | 89.99G 8.11G 3.21G 7.74G 3.35G 268.24G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7240 |
ACID CONCENTRATE 2120 | 67.5G 10.8G 1.61G 7.49G 10.06G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7237 |